Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of molecular glue degrader plus apalutamide in mCRPC
2
Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care
3
Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery
4
Precision Medicine and Patient Selection in mHSPC
5
